Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma. Compton LA, Hiebert SW (2010) Cancer Cell 17: 315-6 Controlling COR competence: BCL-6 regulates neurogenesis and tumor suppression. Chiang C, Ihrie RA (2014) Cancer Cell 26: 773-774 Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM (2002) Immunity 17: 51-62 Histone deacetylase 3 controls a transcriptional network required for B cell maturation. Stengel KR, Bhaskara S, Wang J, Liu Q, Ellis JD, Sampathi S, Hiebert SW (2019) Nucleic Acids Res 47: 10612-10627 B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity. Raybuck AL, Cho SH, Li J, Rogers MC, Lee K, Williams CL, Shlomchik M, Thomas JW, Chen J, Williams JV, Boothby MR (2018) J Immunol 200: 2627-2639 Translating the histone code into leukemia. Linggi BE, Brandt SJ, Sun ZW, Hiebert SW (2005) J Cell Biochem 96: 938-50 A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Hatzi K, Jiang Y, Huang C, Garrett-Bakelman F, Gearhart MD, Giannopoulou EG, Zumbo P, Kirouac K, Bhaskara S, Polo JM, Kormaksson M, MacKerell AD, Xue F, Mason CE, Hiebert SW, Prive GG, Cerchietti L, Bardwell VJ, Elemento O, Melnick A (2013) Cell Rep 4: 578-88
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.